Evidence map›Paper›PMID 23820821›Full record

ArticleBiological psychiatry2014

Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain.

Catherine J Wei, Elisabete Augusto, Catarina A Gomes, Philipp Singer, Yumei Wang, Detlev Boison, Rodrigo A Cunha, Benjamin K Yee, Jiang-Fan Chen

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Caffeine intake and anxiety: a meta-analysis.Frontiers in psychology · 2024
    Pooled it
  2. Article
  3. Modulation of hierarchical motor sequence learning by alpha-synuclein and the adenosine ANeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Adenosine and adenosine receptors in metabolic imbalance-related neurological issues.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
    Review
  8. Retrograde adenosine/ACell reports · 2024
    Article
  9. Targeting the adenosine AChinese journal of traumatology = Zhonghua chuang shang za zhi · 2024
    Review
  10. Adenosine AFrontiers in pharmacology · 2024
    Article
  11. Adenosine ATranslational psychiatry · 2023
    Article
  12. Review
  13. Adenosine ABiomolecules · 2023
    Article
  14. Adenosine ABiomolecules · 2023
    Article
  15. Striatopallidal adenosine ANeuropharmacology · 2023
    Review
  16. Article
  17. Adenosine AMolecular neurobiology · 2022
    Article
  18. The Pharmacological Potential of Adenosine AMolecules (Basel, Switzerland) · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Catherine J WeiMolecular Neuropharmacology Laboratory, Department of Neurology, and Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts.
Elisabete AugustoMolecular Neuropharmacology Laboratory, Department of Neurology, and Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts; Center for Neuroscience and Cell Biology, CNC-University of Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Catarina A GomesCenter for Neuroscience and Cell Biology, CNC-University of Coimbra, Coimbra, Portugal.
Philipp SingerR.S. Dow Neurobiology Laboratories, Legacy Research Institute, Portland, Oregon; Laboratory of Behavioural Neurobiology, Swiss Federal Institute of Technology Zurich, Schwerzenbach, Switzerland.
Yumei WangMolecular Neuropharmacology Laboratory, Department of Neurology, and Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts.
Detlev BoisonR.S. Dow Neurobiology Laboratories, Legacy Research Institute, Portland, Oregon.
Rodrigo A CunhaCenter for Neuroscience and Cell Biology, CNC-University of Coimbra, Coimbra, Portugal; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Benjamin K YeeR.S. Dow Neurobiology Laboratories, Legacy Research Institute, Portland, Oregon; Laboratory of Behavioural Neurobiology, Swiss Federal Institute of Technology Zurich, Schwerzenbach, Switzerland.
Jiang-Fan ChenMolecular Neuropharmacology Laboratory, Department of Neurology, and Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts. Electronic address: chenjf@bu.edu.
Boston University · USLegacy Health · USUniversity of Coimbra · PT

Funding

Epigenetic Markers in Huntington's disease BrainR01NS073947 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MYERS, RICHARD H · 2011 to 2015
$3.1M
NOVEL BENEFIT OF A2A RECEPTOR INACTIVATION IN PD MODELSR01NS041083 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CHEN, JIANG-FAN · 2001 to 2013
$3.1M
Adenosine and schizophrenia: mechanisms and therapiesR01MH083973 · NIMH · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI BOISON, DETLEV · 2009 to 2015
$2.5M
CRCNS-Bioinformatics &ident.:cis-elements: DA receptorsR01DA019362 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CHEN, JIANG-FAN · 2004 to 2008
$1.8M
A1/A2A Receptors and Caffeine PsychostimulationR01NS048995 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CHEN, JIANG-FAN · 2005 to 2009
$1.6M
NIDA NIH HHS R01 DA019362NIDA NIH HHS R01DA19362NIMH NIH HHS R01 MH083973NIMH NIH HHS R01MH083973NINDS NIH HHS R01 NS041083NINDS NIH HHS R01 NS048995NINDS NIH HHS R01NS073947NINDS NIH HHS R01NS41083-10NINDS NIH HHS R01NS48995
6 · The paper itself

Abstract

backgroundAdenosine A2A receptors (A2ARs) are enriched in the striatum but are also present at lower levels in the extrastriatal forebrain (i.e., hippocampus, cortex), integrating dopamine, glutamate, and brain-derived neurotrophic factor (BDNF) signaling, and are thus essential for striatal neuroplasticity and fear and anxiety behavior.

methodsWe tested two brain region-specific A2AR knockout lines with A2ARs selectively deleted either in the striatum (st-A2AR KO) or the entire forebrain (striatum, hippocampus, and cortex [fb-A2AR KO]) on fear and anxiety-related responses. We also examined the effect of hippocampus-specific A2AR deletion by local injection of adeno-associated virus type 5 (AAV5)-Cre into floxed-A2AR knockout mice.

resultsSelectively deleting A2ARs in the striatum increased Pavlovian fear conditioning (both context and tone) in st-A2AR KO mice, but extending the deletion to the rest of the forebrain apparently spared context fear conditioning and attenuated tone fear conditioning in fb-A2AR KO mice. Moreover, focal deletion of hippocampal A2ARs by AAV5-Cre injection selectively attenuated context (but not tone) fear conditioning. Deletion of A2ARs in the entire forebrain in fb-A2AR KO mice also produced an anxiolytic phenotype in both the elevated plus maze and open field tests, and increased the startle response. These extrastriatal forebrain A2AR behavioral effects were associated with reduced BDNF levels in the fb-A2AR KO hippocampus.

conclusionsThis study provides evidence that inactivation of striatal A2ARs facilitates Pavlovian fear conditioning, while inactivation of extrastriatal A2ARs in the forebrain inhibits fear conditioning and also affects anxiety-related behavior.

Indexed as

AnimalsAnxietyConditioning, ClassicalCorpus StriatumFearHippocampusMiceMice, Inbred C57BLMice, KnockoutProsencephalonReceptor, Adenosine A2AReflex, StartleReceptor, Adenosine A2AAdenosine A(2A) receptoranxietyBDNFcortexfear conditioninghippocampusstartle responsestriatum

Identifiers

PMID23820821
PMCPMC4058554
OpenAlexW1974559753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.